in Advanced Ovarian Cancer Patients

University of Michigan, Ann Arbor, MI; Sheba Medical Center, Tel Hashomer, Israel; Assaf. Harofeh Medcl Ctr, Zerifin, Israel; Stanford University Scho...

0 downloads 0 Views 244KB Size

Recommend Documents

Patients with advanced epithelial ovarian cancer (EOC) should be treated with ... tumour angiogenesis, tyrosine kinase inhibitors, review. ... central role played by the key growth factors in the biology .... cediranib at 20 mg/day during chemotherap

Jan 22, 2016 - operative period in order to avert dyspnea [23]. Aim of diaphragmatic .... cytoreduction of ovarian cancer: is there a correlation with “biological.

Mai 50200, Thailand *For correspondence: [email protected] ... The medical records of 29 patients who met the criteria were retrospectively ...

Apr 1, 2017 - mutations in two breast cancer suscepti- bility genes, BRCA1 and BRCA2, using the protein truncation test (PTT). Nine germline mutations were ...

had developed breast cancer under 40 years of age. Using the protein truncation test, we were able to identify three unique. BRCA1 germline mutations (4.8%).

Dec 28, 2012 - The promise of personalized medicine is rapidly becoming a reality for the treatment of .... the AGO-Ovar/AIO and EBMT. J Clin Oncol 2007 ...

Mar 15, 1997 - Our 10-year experience with cisplatinum- based polychemotherapy in 196 advanced ovarian cancer patients previously untreated with.

differences in prognosis. In order to address these issues, we report our experience regarding treatment and prognosis in elderly patients with. FIGO stages ...

Dana-Farber. Cancer. Institute reported that the ad- .... at the Dana-Farber. Cancer. Institute treated patients with .... R., Leonardi,. F., Ccci, G., Passa- lacqua,.

ABSTRACT. Objectives: The aim of this study is to evaluate the results of advanced stage (stage IIIB-IVB) ovarian cancer (OC) patients with intestinal metastasis ...

cytoreduction, we still got the same results with those with suboptimal primary cytoreduction. Key Words: Ovarian cancer - advanced stage - neoadjuvant ...

To determine whether lactase persistence might be related to ovarian cancer risk, in 1994-1995 the authors assessed the capacity to digest lactose by ...

and cediranib (AZD2171, Recentine, AstraZene- ca, Macclesfield, UK), are currently being under investigation7-10. Indeeds, several previous me- ta-analyses ...

Ovarian cancer patients who carry germ-line BRCA1 mutations may have improved survival compared with ovarian cancer patients without these mutations.

Dec 18, 2015 - bevacizumab 15 mg/kg given with paclitaxel and carboplatin followed by ..... gemcitabine, topotecan, pemetrexed or vinorelbine26. There are.

Apr 8, 2017 - anti-idiotypic antibody vaccine ACA125 that functionally imitates the tumor antigen CA125 in 119 patients with ad- vanced ovarian carcinoma.

In the United States, epithelial ovarian cancer is the second leading cause of malignancy affecting the female reproductive tract. As ovarian cancer presents with ...

Apr 4, 2016 - epithelial ovarian cancer is surgical staging followed by adjuvant ... The behavior of fallopian tube and primary peritoneal car- cinomas is ...

breast or ovarian cancer is present. Close medical surveillance, and perhaps even prophylactic oophorectomy, might be justified in high-risk groups. Published ...

Australia. 14 Central Clinical School, Sydney Medical School, University of Sydney, Sydney, New South ... Corresponding author: Skye Dong, School of Psychology, University of Sydney, Chris O'Brien. Lifehouse .... dummy variables with pre-treatment as

advanced thyroid cancer patients who participated in 21 Phase I trials at our center ... tion, RAI, external radiotherapy, thyroid hormone therapy, chemotherapy or ..... cancer cells and blocking alternate signaling pathway. The BRAF V600E ...

advanced cancer patients and data from. 7270 patients showed a pooled prevalence of 30% (Teunissen et al, 2007). Carpenito-Moyet (2007) described anxiety as: 'A state in which an individual experiences feelings of uneasiness and activation of the aut

Apr 19, 2005 - literature search within the main available medical literature databases was performed for .... P.G., and A.V.), and the contribution of an experienced nursing ..... Using and communicating prognostic information should be within the c

Dec 1, 2008 - conditions and good performance status tolerated treatment as well as and ... histopathologic features of the cancers, the OCSG and the GOG ...